(19)
(11) EP 4 583 843 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23777144.9

(22) Date of filing: 08.09.2023
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 31/198(2006.01)
A61P 25/22(2006.01)
 A61K 9/06(2006.01)
A61K 31/4045(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4045; A61K 31/198; A61K 9/0014; A61K 9/06; A61P 25/22; A61K 47/18
 
C-Sets:
  1. A61K 31/4045, A61K 2300/00;
  2. A61K 31/198, A61K 2300/00;
(86) International application number:
PCT/EP2023/074780
(87) International publication number:
WO 2024/052553 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 08.09.2022 US 202217940958

(71) Applicant: Iasomai AB
181 34 Lidingö (SE)

(72) Inventors:
  • PARASASSI, Tiziana
    00194 ROMA (IT)
  • COSTA, Graziella
    00043 CIAMPINO (IT)
  • KRASNOWSKA, Ewa
    00152 ROMA (IT)
  • PITTALUGA, Eugenia
    00195 ROMA (IT)
  • LUNDEBERG, Thomas
    181 90 LIDINGÖ (SE)

(74) Representative: Rouse AB 
P.O.Box 7086
103 87 Stockholm
103 87 Stockholm (SE)

   


(54) COMBINATION COMPRISING N-ACETYL-L-CYSTEINE, SELENOMETHIONINE AND MELATONINE FOR TREATMENT OF ANXIETY DISORDER